CORDIS / Horizon Europe
EU research and innovation projects
Horizon Europe (2021-2027) projects and their participants, from the CORDIS open data published by the European Commission.
23,954EU research projects
TH2ISTLE - RePowering North-East Scotland's Future
- Coordinator
- ABERDEEN CITY COUNCIL* (United Kingdom) · 29 participants
- Period
- 1 May 2026 - 30 Apr 2031
- Maximum EU contribution
- €8,999,051
- Funding scheme
- HORIZON-JU-IA
FlHyPorts - Flemish Hydrogen Ports Valley
- Coordinator
- WATERSTOFNET (Belgium) · 26 participants
- Period
- 1 May 2026 - 30 Apr 2031
- Maximum EU contribution
- €8,972,954
- Funding scheme
- HORIZON-JU-IA
PIAST AIF - PIAST AI Factory
- Coordinator
- INSTYTUT CHEMII BIOORGANICZNEJ POLSKIEJ AKADEMII NAUK (Poland) · 4 participants
- Period
- 1 May 2026 - 30 Apr 2029
- Maximum EU contribution
- €6,250,000
- Funding scheme
- HORIZON-JU-RIA
ICI3D - STRENGTHENING EPIDEMIC MODELLING CAPACITY IN SSA THROUGH THE INTERNATIONAL CLINICS ON INFECTIOUS DISEASE DYNAMICS AND DATA (ICI3D) PROGRAMME
- Coordinator
- EUROPEAN & DEVELOPING COUNTRIES CLINICAL TRIALS PARTNERSHIP (Netherlands) · 6 participants
- Period
- 1 May 2026 - 30 Apr 2029
- Maximum EU contribution
- €1,297,469
- Funding scheme
- HORIZON-JU-CSA
TEST4TPT - AI assisted innovative low-cost skin testing model to accelerate person-centered TB prevention services in Tanzania, Mozambique and Uganda.
- Coordinator
- KONINKLIJKE NEDERLANDSE CENTRALE VERENIGING TOT BESTRIJDING DER TUBERCULOSE (KNCV) (Netherlands) · 8 participants
- Period
- 1 May 2026 - 30 Apr 2029
- Maximum EU contribution
- €2,248,981
- Funding scheme
- HORIZON-JU-RIA
AFRITRAC - AFRICAN TRAINING NETWORK FOR BIOSTATISTICS, EPIDEMIOLOGY AND INFECTIOUS DISEASE MODELLING
- Coordinator
- EUROPEAN & DEVELOPING COUNTRIES CLINICAL TRIALS PARTNERSHIP (Netherlands) · 15 participants
- Period
- 1 May 2026 - 30 Apr 2030
- Maximum EU contribution
- €1,302,444
- Funding scheme
- HORIZON-JU-CSA
EAVI - EUROPEAN-AFRICAN VACCINE INITIATIVE (EAVI): ACCELERATING PREVENTIVE MEASURES AGAINST CHIKUNGUNYA VIRUS IN SUB-SAHARAN AFRICA
- Coordinator
- MEDIZINISCHE UNIVERSITAT INNSBRUCK (Austria) · 8 participants
- Period
- 1 May 2026 - 30 Apr 2031
- Maximum EU contribution
- €13,695,935
- Funding scheme
- HORIZON-JU-RIA
MTBVAC-AVANTE - Advancing a Vaccine for Adolescent/Adult and Neonatal TB Epidemic
- Coordinator
- BIOFABRI SL (Spain) · 13 participants
- Period
- 1 May 2026 - 30 Apr 2030
- Maximum EU contribution
- €18,223,013
- Funding scheme
- HORIZON-JU-RIA
ACT-CHIK - Accelerating Clinical Trials for CHIKungunya Vaccine in Africa
- Coordinator
- INSTITUT PASTEUR (France) · 8 participants
- Period
- 1 May 2026 - 30 Apr 2030
- Maximum EU contribution
- €15,299,932
- Funding scheme
- HORIZON-JU-RIA
SWAB -IMPACT - SWAB-IMPACT: Swab-Based Molecular Testing for Impact on TB Diagnosis and Treatment
- Coordinator
- THE AURUM INSTITUTE NPC (South Africa) · 3 participants
- Period
- 1 May 2026 - 30 Apr 2029
- Maximum EU contribution
- €2,352,076
- Funding scheme
- HORIZON-JU-RIA
STEAM-3D - Sustainable Training in Epidemiological Analysis and Modelling for Data-Driven Decision Making in Africa (STEAM-3D)
- Coordinator
- EUROPEAN & DEVELOPING COUNTRIES CLINICAL TRIALS PARTNERSHIP (Netherlands) · 6 participants
- Period
- 1 May 2026 - 30 Apr 2029
- Maximum EU contribution
- €1,299,702
- Funding scheme
- HORIZON-JU-CSA
PRoRota - SAFETY, EFFECTIVENESS AND COST-EFFECTIVENESS OF PROBIOTICS AS ADJUNCT PREVENTIVE THERAPY FOR CHILDHOOD DIARRHOEA AND ANTIMICROBIAL RESISTANCE IN AFRICA: A DOUBLE BLINDED RANDOMIZED CONTROLLED TRIAL
- Coordinator
- UNIVERSITETET I BERGEN (Norway) · 5 participants
- Period
- 1 May 2026 - 30 Apr 2030
- Maximum EU contribution
- €5,299,999
- Funding scheme
- HORIZON-JU-RIA
MAGNETS - Malaria Genomic Epidemiology and Biostatistics Network for Enhancing Talent in Sub-Saharan Africa
- Coordinator
- EUROPEAN & DEVELOPING COUNTRIES CLINICAL TRIALS PARTNERSHIP (Netherlands) · 7 participants
- Period
- 1 May 2026 - 30 Apr 2029
- Maximum EU contribution
- €1,299,903
- Funding scheme
- HORIZON-JU-CSA
CARE-Africa - Novel Interventions to Identify and Control Diarrhoeal Diseases in Sub-Saharan Africa
- Coordinator
- KING'S COLLEGE LONDON (United Kingdom) · 6 participants
- Period
- 1 May 2026 - 30 Apr 2029
- Maximum EU contribution
- €4,808,786
- Funding scheme
- HORIZON-JU-RIA
PRESERVE - Preparedness, Research and Surveillance Network for infectious Diseases in Central Africa
- Coordinator
- EUROPEAN & DEVELOPING COUNTRIES CLINICAL TRIALS PARTNERSHIP (Netherlands) · 12 participants
- Period
- 1 May 2026 - 30 Apr 2031
- Maximum EU contribution
- €12,484,342
- Funding scheme
- HORIZON-JU-CSA
AddiCAD - FIELD TESTING OF ADDICAD: AN INNOVATIVE DIAGNOSTIC TEST FOR TUBERCULOSIS THAT ADDS TO CAD
- Coordinator
- STELLENBOSCH UNIVERSITY (South Africa) · 6 participants
- Period
- 1 May 2026 - 30 Apr 2029
- Maximum EU contribution
- €2,176,905
- Funding scheme
- HORIZON-JU-RIA
PRECISE-TBM - Prospective evaluation and refinement of novel biomarker-based point-of-care tests for the diagnosis of tuberculous meningitis in children
- Coordinator
- STELLENBOSCH UNIVERSITY (South Africa) · 6 participants
- Period
- 1 May 2026 - 30 Apr 2030
- Maximum EU contribution
- €2,158,289
- Funding scheme
- HORIZON-JU-RIA
HUNADIA - Next-gen cholera treatment for faster recovery, lower mortality and better outbreak control
- Coordinator
- HUNAZINE BIOTECH SL (Spain) · 10 participants
- Period
- 1 May 2026 - 30 Apr 2030
- Maximum EU contribution
- €5,628,263
- Funding scheme
- HORIZON-JU-RIA
T5-TBVAC - EVALUATING A MULTI-VALENT AEROSOL BOOSTER TB VACCINE FOR ADOLESCENTS AND YOUNG ADULTS IN DIVERSE AFRICAN SETTINGS: T5 TBVAC
- Coordinator
- THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (United Kingdom) · 4 participants
- Period
- 1 May 2026 - 30 Apr 2031
- Maximum EU contribution
- €12,687,078
- Funding scheme
- HORIZON-JU-RIA
EpiScientia Network - African National Public Health Institutes (NPHIs) Network of Training In Integrated Health Informatics And Data Sciences, Scaling Up Infectious Disease Modelling.
- Coordinator
- EUROPEAN & DEVELOPING COUNTRIES CLINICAL TRIALS PARTNERSHIP (Netherlands) · 13 participants
- Period
- 1 May 2026 - 30 Apr 2031
- Maximum EU contribution
- €1,299,115
- Funding scheme
- HORIZON-JU-CSA
Data: CORDIS open data (Horizon Europe), imported on 10 Nov 2026. data.europa.eu. Reuse authorised under Commission Decision 2011/833/EU, provided the source is acknowledged.